Debate : Tumor shrinkage (objective response) or clinical benefit rate : Which is the appropriate efficacy endpoint for Metronomic therapy? For Tumor shrinkage Speaker : Dr. Amish Vora, Delhi Please enable JavaScript to view the comments powered by Disqus.